A retrovirus (HTLV-III/LAV/ARV) is the probable causative agent of acquired immune deficiency syndrome (AIDS) (1, 3, 6) . Because this virus can be transmitted by contaminated blood products, blood donors are being screened for the presence of antibody to this agent. In addition, alternative testing sites have been established for individuals who want to know their antibody status. The enzyme immunoassay (EIA) is being used to test these specimens, and this method has been shown to be very sensitive for detecting antibody to the AIDS virus (8) (4) . This process was repeated, and the cells were pelleted at 500 x g for 5 min. The supernatant fluids were clarified at 2,000 x g for 30 min, and the virus was pelleted at 36,000 x g for 2 h. The pellets were collected in 3 ml of 10% (wt/wt) sucrose and layered over a 25%-50% sucrose gradient, which was centrifuged at 78,000 x g for 1 h. The band at the 25o-50% interface was collected, suspended in 50 mM Tris hydrochloride (pH 7.4)-150 mM NaCl-5 mM EDTA (TNE buffer) and centrifuged at 100,000 x g for 1 h, and the pellet was suspended in 0.3 ml of TNE buffer and stored at -60°C. HTLV-III Western blot antigen supplied by Berge Hampar, National Cancer Institute, Bethesda, Md., was used in some of the tests.
The Western blot procedure was performed as described by Tsang et al. (10) . Briefly, the proteins were separated by electrophoresis in a 10% polyacrylamide gel and transferred to nitrocellulose paper, which was cut into 0.5-cm strips. Each 
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reactions on the same plasmas obtained at the VRDL were apparently not valid emphasized the need for verification of positive results in blood donors. Of 74 serum specimens submitted from alternative test sites, 22 were positive by IF. Fifty of these were reactive at local laboratories, and 28 were reactive at the VRDL. Many of these sera, however, were borderline positive, and repeat testing would be expected to give variable results. The two specimens which were EIA negative and IF and Western blot positive were less than 0.6% of the cutoff in the EIA and reacted with the p24 band only in Western blotting.
The EIA test has been shown to be a sensitive method for screening for HTLV-III antibody in blood products, and for this purpose a few false-positive results are acceptable. In this study, plasma gave more EIA false-positive reactions (64%) than did serum specimens (21%), according to IF and Western blotting. This probably reflects the fact that blood donors are in a much lower risk group than those seeking antibody tests at alternative test sites. Because of the mental trauma experienced by an individual notified that he has antibody to the AIDS virus, it is imperative that more specific methods be made available to confirm positive EIA 
